Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome.
about
Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic reviewQuantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracyPosttranslational modifications of transthyretin are serum markers in patients with mycosis fungoidesThymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosisMicroRNA expression in Sezary syndrome: identification, function, and diagnostic potentialThe role of 9-O-acetylated ganglioside D3 (CD60) and {alpha}4{beta}1 (CD49d) expression in predicting the survival of patients with Sezary syndromeGuidelines on the use of extracorporeal photopheresisExpression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage diseaseEvidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group.Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma.Cutaneous T-Cell Lymphoma (Mycosis Fungoides).U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease.Advantages and implications of high dose rate (HDR) total skin electron irradiation (TSEI) for the management of Mycosis Fungoides. Indian experience.Prognostic factors in Sézary syndrome: a study of 28 patients.A trial of fludarabine and cyclophosphamide combination chemotherapy in the treatment of advanced refractory primary cutaneous T-cell lymphoma.Lack of apoptosis of Sézary cells in the circulation following oral bexarotene therapy.Mycosis fungoides and Sezary syndrome: therapeutic approach and outcome in 113 patients.Bexarotene--an alternative therapy for progressive cutaneous T-cell lymphoma? First experiences.Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas.Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.Neoplasms
P2860
Q27000171-D4CF772E-2765-4CDF-A1B9-6ECC5C00C98CQ30477329-D171F0E7-F0E7-4CC9-8A8A-2237B00FD46AQ33280777-CB96BAC3-8490-4AAE-9E2D-D722220EE29FQ34100988-B00CEE69-7E66-4B80-89E2-BBE25815716CQ34122330-8856FB9D-3BB9-4580-8343-995BDEB76E39Q34255140-678B1311-882D-481D-BE9E-61DAE615DE1CQ34918643-46F7CF68-6D97-429F-A4D4-CC15DB62EBF3Q35786883-ACF952D0-C022-4BDD-A781-76B0B45866F1Q36364751-99094971-AD4D-41E9-A847-E889F5E70B24Q36370759-74DE18D2-DF2B-4D18-BA1E-E9FFCC45758BQ37048149-9EC645A5-A227-4D25-A129-CF88F4AA9166Q37074253-743AA54C-9501-4701-A9B3-58A400BBED81Q40624709-0894C64D-DB84-402C-9CF2-2826E566DA27Q42454272-843B378C-3634-4866-B19E-4AB59350F18DQ43612578-6D806713-29DA-48DA-B73B-D10DE40403BAQ46539249-8253D26A-3D6A-433C-A494-8BB6DDF270BEQ46572255-1BE2452E-6B26-4E83-A7F9-80FCD88954CCQ46799392-F56A63BC-0B5C-4EC5-84D3-9FFF64DB9CAFQ53635286-E6200F95-15BD-4D32-B84B-177649B9AE45Q54582099-59DA3B53-D676-41FF-8D09-4C793F2A2240Q56828372-8E11CD68-822B-4742-A3B1-9EA5559C1487
P2860
Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome.
@en
Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome.
@nl
type
label
Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome.
@en
Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome.
@nl
prefLabel
Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome.
@en
Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome.
@nl
P2093
P1433
P1476
Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome.
@en
P2093
P304
P356
10.1001/ARCHDERM.131.9.1003
P577
1995-09-01T00:00:00Z